Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

19 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Completed

A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

NCT05136677

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Local Institution - 0009 Beijing, Beijing Municipality, China
  • Local Institution - 0013 Harbin, Heilongjiang, China
  • Local Institution - 0006 Zhengzhou, Henan, China
  • Local Institution - 0005 Changsha, Hunan, China
View all 21 locations
View Trial Details
Completed

Niraparib Efficacy in Patient With Unresectable Mesothelioma

NCT05455424

Conditions
Adenoma, Disease Attributes, Lung Diseases, +15 more
Locations
  • University Hospital Southampton, Southampton General Hospital Southampton, Hampshire, United Kingdom
  • Medway NHS Foundation Trust, Medway Maritime Hospital Gillingham, Kent, United Kingdom
  • Somerset NHS Foundation Trust, Musgrove Park Hospital Taunton, Somerset, United Kingdom
  • Belfast Health and Social Care Trust, Belfast City Hospital Belfast, United Kingdom
View Trial Details
Completed

Malignant Mesothelioma - Can we Improve Quality of Life

NCT03068117

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia
  • County Durham and Darlington NHS Foundation Trust County Durham, Durham, United Kingdom
  • Basildon and Thurrock University Hospitals NHS Foundation Trust - Basildon Hospital Basildon, Essex, United Kingdom
  • Mid Essex Hospital Services NHS Trust - Broomfield Hospital Chelmsford, Essex, United Kingdom
View all 19 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

NCT03907852

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View Trial Details

Related conditions